Gene Query: PSMB3

Dataset Description Geneva Score
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 81.71
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 38.89
An RNA-centric dissection of host complexes controlling flavivirus infection 38.89
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 37.51
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 35.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 33.67
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 33.67
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 32.5
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 31.68
NRDE2 negatively regulates nuclear exosome functions 26.27
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 24.41
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 23.33
Transcriptome sequencing of K-562 cells 23.12
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 20.62
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 19.56
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 19.35
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 19.35
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 18.36
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 18.36
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 18.33
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 17.77
U1 snRNP telescripting regulates size-function stratified human genome 17.58
Stem and effector CD8 T-cells from human cancers 17.56
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 17.34
The comparison of high-throughput single-cell RNA-seq methods 17.3
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 17.21
Patient-derived luminal breast cancer xenografts with progestins 17.21
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 16.92
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 16.77
Endothelial gene expression analysis 16.77
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 16.69
miR941 overexpression experiment 16.56
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 16.43
LncRNA expression profiling of ischemic stroke patients 16.4
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 16.31
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 16.13
Generation of KRAS signatures using immortalized isogenic lung cells. 16.1
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 15.92
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 15.35
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 15.27
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 15.23
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 15.22
Transcriptome analysis upon C6orf203 silencing 15.09
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 14.87
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 14.78
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.57
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.45
RNA-seq of resting and activated CD4+ T cells +-JQ1 14.44
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 14.43
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 14.43
Transcriptional profiling of microglia; current state of the art and future perspectives 14.41
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.36
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 14.34
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 14.24
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 14.21
Systematic discovery of endogenous human ribonucleoprotein complexes 14.13
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 13.76
Global transcriptome analysis of HAP1 cells 13.73
Mitochondrial dsRNA triggers antiviral signalling in humans 13.67
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 13.66
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 13.52
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 13.47
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 13.38
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.28
Tracking distinct RNA populations using efficient and reversible covalent chemistry 13.17
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 13.03
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 13.02
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 13.02
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 12.93
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.88
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 12.68
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 12.62
Identification of transcription start sites for human A549 cell line using ReCappable-seq 12.56
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 12.54
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 12.53
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 12.48
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.48
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 12.46
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 12.31
Differential expression of genes in AD169-infected MRC5. 12.31
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.26
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.26
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 12.26
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 12.26
mRNA expression profile of Lymphocytes 12.22
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 12.19
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 12.13
Gene expression profiling of leukemia cells following asparagine depletion 12.12
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 12.09
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 11.86
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 11.81
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 11.75
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 11.71
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 11.62
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 11.53
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 11.53
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 11.52
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.23
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 11.23
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.2
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.98
Determining mRNA half-lives on a transcriptome-wide scale 10.97
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.94
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.94
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 10.83
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 10.8
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 10.75
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 10.74
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 10.67
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 10.62
Crizotinib v. DMSO in SW480 cells 10.6
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 10.53
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.47
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 10.45
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 10.45
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 10.45
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 10.38
RNA-Seq in neutrophils from Antiphospholipid Syndrome 10.29
Reassessment of Exosome Composition 10.27
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 10.24
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.24
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.18
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.13
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.13
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 10.09
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 10.09
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 10.07
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.0
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 9.93
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.83
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 9.82
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.79
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 9.68
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.6
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 9.58
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 9.51
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.45
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.44
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 9.43
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 9.4
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.38
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 9.32
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.28
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 9.26
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  9.26
LIN28A Over-expression RNAseq 9.26
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.21
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.21
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 9.06
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 9.06
RNA splicing alteration on glioblastoma and normal neural stem cells 9.03
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.95
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 8.92
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 8.91
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 8.91
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.89
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.89
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.83
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 8.78
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.78
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 8.77
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 8.76
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 8.73
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.7
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.7
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 8.69
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 8.66
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.66
A role for ZNF598 in post-transcriptional gene regulation 8.65
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.59
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 8.56
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 8.53
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 8.53
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.48
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 8.41
A549 cells and MSR-A549 cells 8.41
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 8.38
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 8.38
Global analysis of enhancer targets: Mosaic-seq 8.34
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.33
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 8.33
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.32
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.32
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 8.3
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.29
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.29
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.29
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 8.24
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.21
RNA sequencing of primary human platelets and in vitro cell lines 8.16
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.1
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.08
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 8.06
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.01
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.01
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.01
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.0
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 7.96
Differential gene expression of human melanoma cells [RNA-seq] 7.92
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.92
Expression data from miR340 overexpressing human A549 cells 7.88
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.87
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.84
Genome-wide analysis of the Integrator complex 7.84
Genome-wide analysis of the Integrator complex (HTS) 7.84
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.84
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.78
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 7.75
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 7.7
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.64
Transcription elongation regulates genome 3D structure 7.61
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.6
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.54
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 7.52
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 7.48
MCF-7 as a model for functional analysis of breast cancer risk variants 7.4
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 7.38
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 7.37
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.36
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 7.3
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.29
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 7.27
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.23
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.13
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.12
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 7.1
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.08
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.02
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 7.0
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 6.98
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 6.98
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 6.97
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.92
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 6.88
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 6.87
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 6.86
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.84
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.84
HEK293 Heat-shock experiment 6.84
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.83
Transcriptome landscape of HeLa response upon triamcinolone acetonide 6.82
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 6.78
ARID1A and ARID1B loss in HCT116 cells 6.74
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.64
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.63
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 6.57
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.56
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.55
RNA editing in nascent RNA affects pre-mRNA splicing 6.55
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 6.5
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 6.5
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.43
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.42
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 6.38
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.34
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.31
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.28
Identification of renal resident macrophages across species 6.23
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 6.23
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.16
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.09
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.07
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 6.05
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 6.05
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.04
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.03
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 5.91
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.9
hnRNP C is a key regulator of protein synthesis in mitosis 5.86
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 5.79
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 5.79
Transcriptomic analysis of the HOTAIR-regulated genes 5.77
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 5.72
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.68
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.68
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.63
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.61
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.57
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.55
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.52
Retinoic acid suppresses MYB in adenoid cystic carcinoma 5.49
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 5.49
Positively selected enhancer elements endow tumor cells with metastatic competence 5.43
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.42
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.41
RNAseq of cell lines with knocked in ESR1 mutations 5.4
O-glcnAc reprograms cellular energetics 5.4
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 5.4
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 5.36
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 5.34
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.33
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.29
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.27
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 5.26
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.13
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.1
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.0
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.0
Effect of FGF13 depletion on the H460 cell line 4.99
RNA-seq analysis of breast cancer 4.96
RNA-seq analysis and shRNA screen of breast cancer 4.96
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.94
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 4.94
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.92
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 4.87
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.87
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.86
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.81
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.81
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 4.75
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.72
Loss of CREBBP results in gene expression repression in lymphoma cells 4.72
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.67
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.67
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 4.66
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.64
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.64
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.62
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.62
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 4.61
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 4.51
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.43
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.43
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.41
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.41
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.35
Primary Human B-cell Temporal Response to CD40L Stimulation 4.22
The DPYSL2 gene connects mTOR and schizophrenia 4.2
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.11
Identification of renal resident macrophages across species [C1] 4.1
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.1
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.1
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.1
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.09
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.05
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.03
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.95
SLAM-seq for K562 endogenous mRNA decay 3.95
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 3.91
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.88
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.88
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.86
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.83
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.78
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.78
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.78
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.76
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.76
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 3.76
Comparative Analysis of Cas9 Activators Across Multiple Species 3.72
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 3.7
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.57
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.57
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.53
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 3.51
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.45
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 3.43
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.35
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.34
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.34
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.33
Differential gene expression profiles in imatinib-resistant cell lines 3.33
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 3.31
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 3.31
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.27
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.27
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.26
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.24
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.24
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.24
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.24
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 3.22
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 3.18
RNA-sequencing of healthy human skeletal myocytes 3.1
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.04
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 2.97
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.95
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.88
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.82
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 2.82
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.81
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.76
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.7
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.66
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.65
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.65
The transcriptome effect of overexpressing EZH2 in MCF7 2.65
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.65
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.63
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.63
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.62
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.62
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.61
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.6
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.6
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.59
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.59
Transcriptional landscape changes during human embryonic stem cell derivation 2.58
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.4
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.28
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.23
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.23
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.23
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.22
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.2
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.2
mRNA-sequencing of breast cancer subtypes and normal tissue 2.16
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.15
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.15
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.14
RNA seq with AML (NB4) cells upon FTO inhibition 2.13
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.13
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.13
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.13
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.07
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.02
NAPRT activation of macrophages 1.94
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.93
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.91
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.91
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.85
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.82
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.78
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.78
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.73
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.67
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.64
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.64
K562 polyA RNA-Seq 1.63
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.62
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.59
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.58
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.54
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.53
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.53
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.42
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 1.37
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 1.37
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.37
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.35
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.32
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.32
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.21
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.2
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 1.18
miRNAs affected by antagomiR-17 treatment 1.17
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.15
SF3B1 Degron knockdown RNA-seq 1.13
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.12
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.11
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.07
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.06
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.04
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.02
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.0
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.89
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.89
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.88
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.85
Role of cervicovaginal microbiota in genital inflammation 0.8
EGR1-controlled transcriptome of T HESCs 0.78
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.77
RNA-seq data 0.65
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.63
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.57
An optimization system for isolating and sequencing of single human colon cancer cells 0.55
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.54
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.53
Dermal endothelial cells of type 2 diabetic patients 0.52
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.51
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.49
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.46
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.42
Single-cell analysis of human kidney organoids 0.39
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.37
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.31
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.3
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.3
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.28
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.24
Global transcriptome analysis of WT versus HEB-/- hESCs 0.22
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.21
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.18
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.18
Enhancer activation during EGF response 0.18
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.16
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.14
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.13
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.13
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.13
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.1
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation